DB12351InvestigationalSmall molecule
Siagoside (Sygen, AGF 2) has been investigated for the treatment of Parkinson Disease. It is a naturally occurring substance in the nerve cell’s membrane that is thought to play a... Sygen appears to be beneficial in patients with severe spinal cord injury.
- Formula / weight
- C73H129N3O30 · 1528.826 g/mol (avg)
- Also known as
- Ganglioside GM1 lactone
Resolves to
Structure
InChIKey
WVHBJHLTCHODOA-MYYVOHNDSA-NSMILES[H][C@]1(O[C@@]2(C[C@H](O)[C@H]1NC(C)=O)O[C@H]1[C@@H](O[C@@H]3O[C@H](CO)[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O)[C@H]3NC(C)=O)[C@@H](CO)O[C@@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](OC[C@H](NC(=O)CCCCCCCCCCCCCCCCC)[C@H](O)\C=C\CCCCCCCCCCCCC)O[C@@H]3CO)[C@@H]1OC2=O)[C@H](O)[C@H](O)COWhat you can answer from here — as of May 14, 2021
Which companies are running trials of Siagoside, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account